↓ Skip to main content

Dove Medical Press

Non-Alcoholic Steatohepatitis (NASH) – A Review of a Crowded Clinical Landscape, Driven by a Complex Disease

Overview of attention for article published in Drug Design, Development and Therapy, September 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
1 news outlet
twitter
18 X users

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
130 Mendeley
Title
Non-Alcoholic Steatohepatitis (NASH) – A Review of a Crowded Clinical Landscape, Driven by a Complex Disease
Published in
Drug Design, Development and Therapy, September 2021
DOI 10.2147/dddt.s315724
Pubmed ID
Authors

Julia M Fraile, Soumya Palliyil, Caroline Barelle, Andrew J Porter, Marina Kovaleva

X Demographics

X Demographics

The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 130 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 130 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 12%
Student > Ph. D. Student 12 9%
Student > Master 8 6%
Student > Bachelor 7 5%
Unspecified 6 5%
Other 19 15%
Unknown 63 48%
Readers by discipline Count As %
Medicine and Dentistry 15 12%
Biochemistry, Genetics and Molecular Biology 14 11%
Pharmacology, Toxicology and Pharmaceutical Science 10 8%
Unspecified 6 5%
Agricultural and Biological Sciences 4 3%
Other 15 12%
Unknown 66 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 June 2023.
All research outputs
#1,743,543
of 25,584,565 outputs
Outputs from Drug Design, Development and Therapy
#75
of 2,254 outputs
Outputs of similar age
#40,442
of 434,423 outputs
Outputs of similar age from Drug Design, Development and Therapy
#2
of 43 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,254 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,423 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.